State of Alaska Department of Revenue Decreases Position in Align Technology, Inc. $ALGN

State of Alaska Department of Revenue decreased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 6.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,665 shares of the medical equipment provider’s stock after selling 555 shares during the period. State of Alaska Department of Revenue’s holdings in Align Technology were worth $1,451,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Compagnie Lombard Odier SCmA purchased a new position in Align Technology in the first quarter valued at about $32,000. Center for Financial Planning Inc. purchased a new position in Align Technology in the first quarter valued at about $35,000. SVB Wealth LLC purchased a new position in Align Technology in the first quarter valued at about $36,000. Farther Finance Advisors LLC raised its stake in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 92 shares in the last quarter. Finally, Mather Group LLC. raised its stake in Align Technology by 375.0% during the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 345 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Insider Transactions at Align Technology

In other news, CEO Joseph M. Hogan purchased 7,576 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were purchased at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the purchase, the chief executive officer directly owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.66% of the stock is owned by corporate insiders.

Align Technology Price Performance

Shares of NASDAQ:ALGN opened at $132.17 on Friday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The stock has a market capitalization of $9.58 billion, a P/E ratio of 22.29, a P/E/G ratio of 1.45 and a beta of 1.70. The business has a 50-day moving average of $140.20 and a two-hundred day moving average of $165.72.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the firm posted $2.41 EPS. Align Technology’s revenue for the quarter was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. As a group, research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to repurchase up to 2% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

Several analysts have issued reports on ALGN shares. Wells Fargo & Company cut their price objective on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Align Technology in a research note on Saturday, September 27th. Stifel Nicolaus cut their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a research note on Thursday, July 31st. Piper Sandler cut their price objective on Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. Finally, Evercore ISI upped their price objective on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a research note on Wednesday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $215.00.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.